NC Gene Editing Co. Launches IPO That Could Raise $134M
North Carolina-based Precision BioSciences Inc. on Monday launched an initial public offering that could raise as much as $134.3 million if the genome editing company's shares price at the top of...To view the full article, register now.
Already a subscriber? Click here to view full article